Research & KnowledgeEvent: September 2, 2026
Baseimmune published an article discussing the future of AIxBio, emphasizing smart scientists, frontier models, specialist models, proprietary data, and experiments in the loop.
Published
Signal category
Research & Knowledge
Quote
“If you're unsure about where AI now sits in science, then you MUST read this article.”
— Joshua Blight|Baseimmune team
Company
Baseimmune
Pioneering the next generation of active immunotherapies for chronic diseases
- Industry
- Biotechnology Research
- Location
- London, GB
- Company size
- 28 employees
Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.
Founded 2019